The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The In-Situ Hybridization Market Expected To Reach Based On Its 2026 Value?
The in-situ hybridization market has experienced robust growth in recent years. It is forecast to increase from $1.78 billion in 2025 to $1.94 billion in 2026, with a compound annual growth rate (CAGR) of 9.5%. The historical market expansion is attributable to several factors, including the broadening scope of molecular pathology applications, an uptick in cancer biomarker testing, more widespread use of fluorescence microscopy, the advancement of academic genomics research, and the rising integration of ish in infectious disease studies.
The in-situ hybridization market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $2.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.1%. This expansion during the projection period is primarily driven by an increasing need for precision oncology diagnostics, the growing incorporation of AI-powered image analysis, the broadening scope of personalized medicine research, heightened investments in molecular diagnostics infrastructure, and advancements in probe technologies. Key developments expected within this period encompass wider acceptance of multiplex ISH techniques, increased deployment of automated slide scanning systems, a surging need for high-resolution spatial gene expression analysis, further integration of digital pathology, and a sharpened emphasis on companion diagnostics.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report
Which Major Drivers Are Influencing The Expansion Of The In-Situ Hybridization Market?
The increasing occurrence of cancer is projected to propel the expansion of the in-situ hybridization market in the coming years. Cancer is characterized by the uncontrolled proliferation of abnormal cells that can invade or spread to other parts of the body. The escalation in cancer cases is attributed to longer life expectancy, as aging provides more time for genetic mutations to accumulate and for individuals to be exposed to cancer-causing factors. In-situ hybridization (ISH) is vital in cancer management, enabling the detection of specific genetic abnormalities within tumor cells. It is employed for accurate diagnosis, prognosis, and guiding targeted therapy decisions. For instance, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, indicated that new cancer cases are expected to exceed 35 million in 2050, signifying a 77% increase from the estimated 20 million cases in 2022. Hence, the rising incidence of cancer will significantly bolster the growth of the in-situ hybridization market.
What Are The Main Segments Within The In-Situ Hybridization Market Segment Structure?
The in-situ hybridization market covered in this report is segmented –
1) By Product: Analytical Instruments, Kits And Reagents, Software And Services, Other Products
2) By Technology: Fluorescence In Situ Hybridization, Chromogenic In Situ Hybridization, Dual-Color In Situ Hybridization
3) By Application: Cancer Diagnosis, Cytogenetics, Developmental Biology, Infectious Diseases, Immunology, Other Applications
4) By End User: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Contract Research Organizations, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Analytical Instruments: Fluorescence Microscopes, Brightfield Microscopes, Automated Slide Scanners, Hybridization Systems
2) By Kits And Reagents: DNA Probes, RNA Probes, Labeling Kits, Detection Reagents, Pretreatment Reagents
3) By Software And Services: Image Analysis Software, Data Management Software, Custom Probe Design Services, Sample Preparation Services
4) By Other Products: Slides And Coverslips, Storage Reagents, Hybridization Buffers, Control Probes
Which Trends Are Shaping The In-Situ Hybridization Market?
Companies operating in the in-situ hybridization market are focusing on developing advanced solutions, such as HER2 testing solutions, to help predict how patients will respond to targeted therapies. HER2 testing solutions are diagnostic instruments utilized to identify the presence and level of the HER2 protein in cancer cells, thereby aiding in targeted treatment decisions. For instance, in December 2023, Cytelabs, an India-based cancer diagnostic services provider, introduced dual in situ hybridization (DISH) testing for breast cancer patients. DISH technology, approved by the US FDA, represents a significant improvement in accurate HER2 testing, which is essential for targeted breast cancer treatment. It considerably reduces the waiting time by providing HER2 status results within 24 to 48 hours, helping to lessen the stress experienced by patients and their families. By offering dependable results quickly, DISH facilitates prompt treatment planning and initiation. Since HER2 status plays a crucial role in determining prognosis and therapy, precise and efficient testing is indispensable for the proper evaluation of all invasive breast cancers.
Who Are The Companies Participating In The In-Situ Hybridization Market?
Major companies operating in the in-situ hybridization market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen NV, Bio-Techne Corporation, Leica Biosystems Nussloch GmbH, Biocare Medical LLC, BioGenex Srl, Oxford Gene Technology Inc., Creative Biolabs, Empire Genomics LLC, Abnova Corporation, BioView Ltd., Advanced Cell Diagnostics Inc., BioCat GmbH, Bio SB Inc., Genemed Biotechnologies Inc.
Get The Full In-Situ Hybridization Market Report:
https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report
Which Region Dominates The In-Situ Hybridization Market By Market Share?
North America was the largest region in the in-situ hybridization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-situ hybridization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized In-Situ Hybridization Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report
Browse Through More Reports Similar to the Global In-Situ Hybridization Market 2026, By The Business Research Company
Hybrid Cloud Market Report 2026
https://www.thebusinessresearchcompany.com/report/hybrid-cloud-global-market-report
Hybrid Seeds Market Report 2026
https://www.thebusinessresearchcompany.com/report/hybrid-seeds-global-market-report
Biocomposites Market Report 2026
https://www.thebusinessresearchcompany.com/report/biocomposites-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model